Anne Wojcicki

Co-founder and CEO, 23andMe

Industry: Health Data Infrastructure
Based in: United States
Company funding: $900M raised
Region: North America

Biologist and healthcare investor who co-founded consumer genetics in 2006.

Made consumer genetic testing a mainstream product category.

Anne Wojcicki is an American entrepreneur who studied biology at Yale University before working as a healthcare investment analyst. In 2006 she co-founded 23andMe, the direct to consumer genetic testing company, and served as its chief executive, guiding it through a public listing and years of growth in personal genomics.

23andMe in the startup database Company website LinkedIn

The journey

How Anne Wojcicki got here, step by step.

1996
Graduated from Yale University
She earned a bachelor of science degree in biology from Yale University.
1990s to 2000s
Healthcare investment analyst
Wojcicki worked as a healthcare investment analyst, studying biotechnology and pharmaceutical companies on Wall Street.
2006
Co-founded 23andMe
She co-founded 23andMe with Linda Avey and Paul Cusenza to bring genetic testing directly to consumers.
2015
Regulatory path reopened
23andMe won authorisation to return health reports to consumers, a milestone for the whole consumer genomics field.
2021
Took the company public
23andMe became a publicly traded company through a merger with a special purpose acquisition company.
2006 to 2025
Led 23andMe as chief executive
Wojcicki led the company for almost two decades as it built one of the largest consented genetic databases in the world.